1. Home
  2. FGEN vs NSYS Comparison

FGEN vs NSYS Comparison

Compare FGEN & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • NSYS
  • Stock Information
  • Founded
  • FGEN 1993
  • NSYS 1981
  • Country
  • FGEN United States
  • NSYS United States
  • Employees
  • FGEN N/A
  • NSYS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • NSYS Industrial Machinery/Components
  • Sector
  • FGEN Health Care
  • NSYS Technology
  • Exchange
  • FGEN Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • FGEN 34.5M
  • NSYS 29.0M
  • IPO Year
  • FGEN 2014
  • NSYS N/A
  • Fundamental
  • Price
  • FGEN $0.50
  • NSYS $10.70
  • Analyst Decision
  • FGEN
  • NSYS
  • Analyst Count
  • FGEN 0
  • NSYS 0
  • Target Price
  • FGEN N/A
  • NSYS N/A
  • AVG Volume (30 Days)
  • FGEN 1.1M
  • NSYS 5.5K
  • Earning Date
  • FGEN 02-24-2025
  • NSYS 03-19-2025
  • Dividend Yield
  • FGEN N/A
  • NSYS N/A
  • EPS Growth
  • FGEN N/A
  • NSYS 109.80
  • EPS
  • FGEN N/A
  • NSYS 1.55
  • Revenue
  • FGEN $180,015,000.00
  • NSYS $135,567,000.00
  • Revenue This Year
  • FGEN $21.91
  • NSYS N/A
  • Revenue Next Year
  • FGEN N/A
  • NSYS N/A
  • P/E Ratio
  • FGEN N/A
  • NSYS $6.74
  • Revenue Growth
  • FGEN 16.15
  • NSYS N/A
  • 52 Week Low
  • FGEN $0.18
  • NSYS $9.53
  • 52 Week High
  • FGEN $2.93
  • NSYS $19.15
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 49.50
  • NSYS 57.14
  • Support Level
  • FGEN $0.46
  • NSYS $9.84
  • Resistance Level
  • FGEN $0.51
  • NSYS $10.38
  • Average True Range (ATR)
  • FGEN 0.05
  • NSYS 0.34
  • MACD
  • FGEN -0.01
  • NSYS 0.07
  • Stochastic Oscillator
  • FGEN 31.25
  • NSYS 83.74

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

Share on Social Networks: